Skip to main content

Table 4 Effects of gabexate mesilate on the outcome of the patients

From: A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis

  Survivors Nonsurvivors Mortality (%) Pvalue
Gabexate mesilate and antithrombin 14 2 12.5  
Gabexate mesilate 15 2 11.8  
     1.000
Use of gabexate mesilate 29 4 12.1  
Nonuse of gabexate mesilate 24 3 11.1  
     1.000